BRIEF CO‐ADMINISTRATION OF IDELALISIB MAY IMPROVE THE LONG‐TERM EFFICACY OF FRONTLINE CHEMOIMMUNOTHERAPY IN CHRONIC LYMPHOCYTIC LEUKAEMIA: 3‐YEAR FOLLOW‐UP FROM THE RIALTO TRIAL

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.217-218
Main Authors: Pettitt, A., Kalakonda, N., Cicconi, S., Murphy, C., Menon, G., Coupland, S.E., Oates, M., Lin, K., Pocock, C., Jenkins, S., Schuh, A., Wandroo, F., Rassam, S., Duncombe, A.S., Cervi, P., Paneesha, S., Aldouri, M., Fox, C., Knechtli, C., Hamblin, M., Turner, D., Hillmen, P.
Format: Article
Language:English
Subjects:
Chronic lymphocytic leukemia
Leukemia
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.32_2630